Cactus Pharmaceuticals Private Limited, a active private limited company, was established on 22 January 2014 in Greater Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100UP2014PTC062147. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Cactus Phermaceuticals Private Limited. It upholds a compliant status. Its leadership includes Raihana Khatun (Director), Mohammad Muntazir (Managing Director), Yasir Zobair (Director). Past directors included Mohammad Muntazir. It holds ₹1.15 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-3/306, Plot No- 40-45, Knowledge Park V Greater Noida, Greater Noida, Uttar Pradesh, 201308.
U24100UP2014PTC062147
062147
22 January 2014
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Cactus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raihana Khatun | Director | 22 Jan 2014 | Current |
| Mohammad Muntazir | Managing Director | 22 Jan 2014 | Current |
| Yasir Zobair | Director | 27 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cactus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.28% increase. The company also saw a substantial improvement in profitability, with a 19.48% increase in profit. The company's net worth Soared by an impressive increase of 43.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Cactus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,149,876.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2021 | Hdfc Bank Limited | ₹1.15 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cactus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cactus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cactus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Yasir Zobair was appointed as a Director was appointed as a Director on 27 Mar 2025 & has been associated with this company since 8 months 6 days . was recorded as a recent event.
Cactus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Cactus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.15 M with Charge ID 100504917 was registered on 05 Oct 2021. was documented.
Progress on Raihana Khatun was appointed as a Director was appointed as a Director on 22 Jan 2014 & has been associated with this company since 11 years 10 months . was documented.
Mohammad Muntazir was appointed as a Managing Director was appointed as a Managing Director on 22 Jan 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
The CIN of Cactus Pharmaceuticals Private Limited is U24100UP2014PTC062147.
Cactus Pharmaceuticals Private Limited is headquartered at B-3/306, Plot No- 40-45, Knowledge Park V Greater Noida, Greater Noida, Uttar Pradesh, 201308.
Cactus Pharmaceuticals Private Limited was incorporated on 22 January 2014.
The current directors of Cactus Pharmaceuticals Private Limited are
The primary industry of Cactus Pharmaceuticals Private Limited is Trade.
Cactus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cactus Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Cactus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX